To try and Fail is better than Failing to never try at all!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Patience= The capacity to accept or tolerate delay, trouble, or suffering without getting angry or upset. Been here for years, got in originally @ .005. This is not a day trader forte.
DUBLIN, Oct. 9, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/jhq4b3/global_bottled) has announced the addition of the "Global Bottled Water Market 2015-2019" report to their offering.
The global bottled water market in terms of revenue and volume to grow at a CAGR of 7.40% and 6.18%, respectively, during 2014-2019.
This report covers the present scenario and the growth prospects of the global bottled water market for 2014-2019. To calculate the market size, the report considers revenue generated from the retail sales of bottled water.
The market size is calculated based on revenue and volume. Based on products type, the global bottled water market can be classified into sparkling flavored, sparkling unflavored, still flavored, and still unflavored. The report also covers the segmentation of the market based on the sales of bottled water using various distribution channels such as supermarkets/hypermarkets, on-trade, independent retailers, and convenience stores.
As the popularity of bottled water increases worldwide, it has become imperative for governments to regulate the industry, because safe water is a critical public health issue. Under the Act, manufacturers are responsible for producing safe, wholesome, and truthfully labeled food products, including bottled water products. The Food and Drug Administration inspects the manufacturers to ensure that the bottled water is purified, processed, bottled, and transported under sanitary conditions. Companies need to meet all the procedures and regulations set by the Food and Drug Administration. Similarly, governments in many countries have started taking initiatives to ensure the safety of bottled water. This will help remove unethical practices in the industry and ensure the provision of safe and purified water. This trend will have both positive and negative influence on the market.
According to the report, the global average per capita consumption of bottled water in 2007 was 7.6 gallons, and it increased to 9.2 gallons in 2012. The increased prevalence of waterborne diseases and scarcity of tap water in many countries create a high demand for bottled water. In addition, bottled water is convenient because boiling water at home is time-consuming and is not energy-efficient. It also has consistent taste and quality, making it the preferred choice for travelers. Bottled mineral water is purified and fortified with dissolved minerals, thereby providing consumers with an added health benefit. The need to provide safe drinking water and the growing population in developing countries such as India and countries in the Middle East have made these countries favorable destinations for multinational bottled water manufacturers.
Further, the report states that bottled water companies are pressured to reduce their prices and offer competitive products to avoid losing market share.
Key vendors
•Coca-Cola
•Danone
•Nestlé
•PepsiCo
Other prominent vendors
•Aqua Gold International
•Bisleri International
•Boreal Water Collection
•China Water & Drinks
•Icelandic Water Holdings
•Isbre Holding
•Suntory Water Group
•VOSS of Norway
For more information visit http://www.researchandmarkets.com/research/jhq4b3/global_bottled
Media Contact:
Laura Wood, +353-1-481-1716, press@researchandmarkets.net
Current Information:
NYSHD Cert. #124
Boreal Water Collection, Inc.
PO Box 220
Kiamesha Lake, NY 12751
(845) 794-0400
https://www.health.ny.gov/environmental/water/drinking/bulk_bottle/bottled.htm#one-hundred-twenty-four
Good Morning,
I just wanted to say in reading these boards you have been the first I have ran across to have a very knowledgeable background/Keen eye and actually share the information, "GEQU". I am not a member and can not reply but I am requesting to get you opinion when time is available on "GNPT", I am looking today possibility to make a small investment, and would appreciate the information be sent to the following email below:
Larry.Sauerheber@HII-Ingalls.com
Thanks again Sir.
Arrayjet Inks $600k Contract with CDI Laboratories
Sep 23, 2015 | a GenomeWeb staff reporter
.
NEW YORK (GenomeWeb) – Scottish microarray instrument maker Arrayjet today announced it has won a contract with CDI Laboratories.
Under the terms of the contract, valued at more than $600,000, CDI will use Arrayjet's Ultra Marathon II high-throughput microarray printer to make its HuProt proteomics arrays and custom microarrays.
"This is a significant contract for us," Arrayjet CEO Iain McWilliam said in a statement. "Not only does it have an exceptionally strong international focus, but strengthens our proposition as the leading provider of microarray printing know-how and technology."
When I checked this morning on Swab account my funds were deposited and has been settled.
FYI,
After receiving the dividends in my Charles Swab account I contacted my financial representative to see when actual funds would be credited to money market account. He stated "generally 1-3 days to see in account, but being a "Small Cap" as he stated and I asked him for his personnel experience, he has seen up to 2-3 weeks from data of issue before actual money deposited. With that said I am just waiting.
Thank you again for your interest. At this time I am unable to confirm any plans to effect a reverse split. The company does desire to be listed on a National exchange and would need to meet certain share price requirements within the quantitative listing standards to do so however, timing and process may provide many options and I unable to state that a reverse split will be necessary. That said, management will consider all options to accomplish their goals and I will be certain to advise you once those decisions are discussed publicly. Until then please let me know if I might be of further assistance.
Best regards,
Derek Gradwell
MZ Group | Senior Vice President, Natural Resources – MZ North America
Main: 212-301-7130
Direct: 512-270-6990
dgradwell@mzgroup.us | www.mzgroup.us
Download my Vcard |
Press Releases
HII Technologies, Inc. Announces Two New Customer Wins for Bacteria Testing and Removal
Download PDF
HOUSTON, TX -- (Marketwired) -- 03/10/15 -- HII Technologies, Inc. (OTCQB: HIIT) ("HII Technologies" or the "Company"), an oilfield service company focused in frac water management with supporting divisions in oilfield power and safety services, today announced it has new agreements with two major E&P companies in West Texas to provide on-site testing and elimination of bacteria using the Company's AES HydroFLOW® and Rapid-B™ test technologies.
Bacteria introduced into a well causes a range of problems that may damage the producing formation, cause corrosion, and result in loss of production. The cost of treating Microbiologically Influenced Corrosion (MIC) is estimated to be hundreds of millions of dollars per year, and hundreds of thousands of dollars for a single well. The traditional approach for preventing bacteria build-up has been to use oxidants and biocides to treat bacteria in water prior to it going downhole for fracing. Previous testing techniques required operators to wait one to three weeks for results and by the time the sample results were produced, some bacteria have survived the biocide treatment and remained in the water. The Vivione Rapid-B™ system makes in-field bacteria testing available in real time so that quantitative data can be used to calculate dosing of biocides. The Rapid-B™ system in combination with AES HydroFLOW® successfully destroys up to 99% of bacteria in water without the use of chemicals resulting in cost savings for operators in the field.
A major E&P company with a market capitalization of over $50 billion hired AES Water Solutions to test for bacteria in water and frac fluids in West Texas in order to systematically identify potential points of bacterial contamination throughout all stages of the frac. AES dispatched a mobile bacteria testing lab and collected fluid samples at each key point in the process, including discrete samples of various size proppants and gels. The Rapid-B™ technology was able to provide living bacteria counts within 15 minutes of initiating the test, resulting in identification of several samples with high bacteria levels detected after the biocide treatment. Rapid-B™ identified quantitative values for living bacteria allowing time to apply additional treatment of biocides based on real-time data before the fluid entered the formation.
Another major E&P company with large drilling and completion programs in West Texas began using the AES HydroFLOW® to kill bacteria in fresh and produced water pits, which resulted in maintained lower bacteria levels in stored water without use of chemicals. AES Water Solutions attached HydroFLOW® devices on the exterior of pipelines used to recirculate water in large pits (~250,000 bbls) and ruptured the cells of bacteria in the water. When compared with periodic dosing of oxidants which were no longer present in the water after the initial reaction, the HydroFLOW® continuously treated the water with greater long term effectiveness at neutralizing bacteria, and at a significantly reduced cost per month. The customer engaged AES Water Solutions to operate HydroFLOW® units during water transfer to a hydraulic fracturing operation for on-the-fly bacteria treatment.
"We are pleased to announce these new customer wins with active oilfield operators for the testing and removal of bacteria using AES HydroFLOW® systems," said Brent Mulliniks, President of AES Water Solutions. "Both contracts are with new customers in our core operating region of West Texas. This progress provides further evidence of the demand for the commercialization of AES HydroFLOW® and Rapid-B™ systems. The additions of large new customers gives us confidence that we can expect growth in this segment in an environment where the single service providers are losing market share to full bundled service providers."
The HydroFLOW® system provides lower cost bacteria treatment than chemicals (up to 70% savings), and is supported by testing from the Vivione Rapid-B™ that validates HydroFLOW's® effectiveness. HydroFLOW® is able to not only reduce the cost for neutralizing bacteria, but also considerably reduces the footprint and traffic of treatment equipment. AES Water Solutions provides a cost-competitive combination of water transfer and bacteria neutralization that saves time, cost and significantly reduces the footprint of on-site equipment.
About HII Technologies, Inc.
HII Technologies, Inc. is a Houston, Texas based oilfield Services Company focused on Total Frac Water Management with operations in the Southwest United States. It has two supporting divisions in oilfield power management and safety services. By focusing on the critical service areas of Water, Safety and Power, the Company's bundled services approach has allowed them to become a cutting edge technology provider and cost saving solution to oilfield operators who are looking for ways to improve efficiencies in the current price environment. The Company's frac water management division does business as AES Water Solutions, Hamilton and AquaTex, its onsite oilfield contract safety consultancy does business as AES Safety Services and its mobile oilfield power subsidiary does business as Sage Power Solutions, formerly South Texas Power (STP). HII Technologies' objective is to bring proven technologies to these operating divisions to build a long-term competitive advantage for its stakeholders. Read more at www.HIITinc.com, www.AESWaterSolutions.com, www.AquaTexUSA.com, www.HamiltonFracWater.com, www.AESSafetyServices.com and www.Oilfield-Generators.com.
Embedded Video Available: https://vimeo.com/110159146
Investor Relations Contact
Derek Gradwell
SVP Natural Resources
MZ Group North America
Phone: 512-270-6990
Email: dgradwell@mzgroup.us
Web: www.mzgroup.us
Source: HII Technologies, Inc.
Released March 10, 2015
Minerco's Level 5 Aquires Avanzar
Maker of VitaminFIZZ® Integrates Distribution Company into its Portfolio
Minerco Resources, Inc. (OTC: MINE), parent company of Level 5 Beverage Company, Inc., the makers of VitaminFIZZ® and Coffee Boost™, announced on October 27, 2014 that Level 5 has acquired controlling interest in Avanzar Sales and Distribution, LLC in California.
Avanzar is a leading full service broker and distributor of world-class consumables and products. The
company covers the Southern California retail marketplace and currently services over 3,200 locations. Avanzar's expertise is in nurturing innovative brand development through every step of the process. Their portfolio of over 20 progressive brands is highlighted by: VitaminFIZZ, Cabana Natural Lemonades and Coconut Water, Fruzinga, Popcornopolis and JAK E-cigs.
In FY2013, Avanzar generated annual sales of approximately $2,600,000.00. The company's projected revenue for FY2014 is approximately $2,700,000. Based in Brea, California, Avanzar employs 19 full-time staff and has a fleet of 10 trucks (including refrigerated trucks). With the support of Level 5, Avanzar's Gross Revenues are projected to be $5,500,000.00 in 2015 and continued exponential growth in 2016.
Level 5's acquisition of the controlling interest of Avanzar was made in affiliation with Minerco, the parent company of Level 5. Under the terms of the deal, Level 5's structured payments of $500,000 yields Level 5 an irrevocable majority voting interest (51%) and an initial 30% equity percentage. The use of proceeds is to be deployed entirely and solely to expand Avanzar's distribution business and not to be paid to Avanzar shareholders. Level 5 also has the option to purchase an additional 21% equity stake at a fixed price and another option to purchase up to 75% of the total equity of Avanzar at a fixed multiple of revenues.
Avanzar's Bill Juarez will continue his role as President of the company, and his entire staff will remain unchanged. The investment portends an expansion of Avanzar's resources to increase its distribution footprint within Southern California and the Southwest Region. In 2015, with the support of Level 5 and VitaminFIZZ, expansion outside of the region is planned with preliminary expansion targets already identified and/or currently in negotiations through Drink King.
"We are thrilled about the prospects for this new partnership with Level 5 and the expansion opportunities that are now possible," said Juarez. "Level 5 has demonstrated an ability to exceed expectations this past year as they developed and launched VitaminFIZZ, and we look forward to capitalizing on our combined strength in the market."
Part of VF Distribution pipeline
http://drinkking.com/
A Publication Describing the First Treatment of Ebola with the Aethlon Hemopurifier®
Posted on Thursday, February 12th, 2015 at 2:36 pm
47 2 36 Google +2
In my last article published on “The Chairman’s Blog,” I discussed factors underlying the increased incidence of viral epidemics, disclosed that we launched our first FDA approved clinical study and shared mechanistic details underlying our vision for treating infectious viral pathogens. Instead of deploying a drug mechanism to inhibit the replication of a single viral species, I referenced that we created the Aethlon Hemopurifier® to capture broad-spectrum circulating viruses (including many viruses not treatable with antiviral drugs) through lectin affinity attachment to a unique structure that viruses co-opt from host cells during replication. To be more specific, this unique structure resides on glycoproteins that coat the surface of infectious viruses. In well studied viruses such as HIV, it is clearly understood that virally shed glycoproteins play a role in immune suppression (the hallmark of AIDS) and perform other deleterious mechanisms to enable continued progeny virus replication. Beyond the broad-spectrum clearance of infectious viruses, an under-appreciated mechanism of Hemopurifier® therapy is its ability to capture glycoproteins once they shed from the surface of the virus.
Yesterday, the journal “Blood Purification” published a manuscript describing the first administration of Hemopurifier® therapy to an Ebola patient. The publication is entitled, “Extracorporeal Virus Elimination for the Treatment of Severe Ebola Virus Disease – First Experience with Lectin Affinity Plasmapheresis.” The lead author of the publication administered Hemopurifier® therapy to an infected patient at Frankfurt University Hospital in Germany. The publication reports that 253 million copies of Ebola virus were captured within the Hemopurifier® during a single 6.5 hour treatment. Additionally, based on pre and post treatment measurements, a 63-fold reduction in viral load was observed. The paper also discusses the mechanism of the Hemopurifier® to eliminate Ebola glycoproteins, which the authors identify as decoys that neutralize antibody response and trigger lymphocyte apoptosis. The authors also report that shed glycoproteins induce a massive release of cytokines and increase vascular permeability, which in turn leads to: systemic inflammation, electrolyte disturbances, septic shock-like syndrome, multi-organ failure, and death. The article can be accessed online at: http://www.karger.com/Article/Abstract/375229
I look forward to keeping you updated on the progress of our Hemopurifier® therapy and thank you for taking the time to read this blog.
Leave a Reply
You must be logged in to post a comment.
hooseerfan
February 12, 2015 - 7:29 pm
Please Mr Joyce respond to your shareholders cries for more communication. We all believe in the HP but where are we going from here after our success in helping treat DR Mawanda but he has been the one and only patient? How can you not see the stress the rapid rise and fall of the stock has been on the long term shareholders. The lack of communication including no reassurances that the data presented was accurate and of great importance in the recovery of Dr Mawanda even after the attacks from outside financial bloggers, We have received no explanation of why it was necessary to go to predatory financiers in order to obtain funding for the trials which has literally taken millions away from the market and shareholder value.
Log in to Reply
James Joyce
James Joyce
February 13, 2015 - 10:54 am
I appreciate your comment and recognize and value you as a long-term shareholder. I hope you enjoyed the first scientific journal account depicting the successful deployment of our Hemopurifier® to treat a comatose ebola patient with multiple organ failure. In regards to communications, you may have noted (as reflected in our SEC filings) that on December 30th we filed an S-1 registration statement that was subsequently deemed effective by the SEC at the end of January. During the period this registration statement was pending with the SEC, our communications were constrained. In regards to our most recent financing, it placed a $90 million+ valuation on our company based on a straight equity structure. It was the highest financing valuation in the history of our organization and was priced approximately 100% higher than a transaction completed the previous month. We closed the financing with a single institutional healthcare investor and it was managed by Roth Capital, a well established small-cap investment banking firm that has raised more than $10.6 billion for its clients. Beyond reducing balance sheet risk, the transaction provided resources to conduct our FDA approved study, which represents the foundation of a multi-indication U.S. clinical progression model to optimize long-term shareholder value. It also allowed us to clean up certain past due debts as reflected in the 10-Q we filed with the SEC earlier this week. As reported in the 10-Q, debt reduction and equity financings contributed to a $16 million positive shift in shareholder equity since our 3/31/14 fiscal year end.
Log in to Reply
hooseerfan
February 16, 2015 - 2:23 pm
Sorry Mr Joyce, I have not been back to see your reply but thankfully a poster on Investors Village posted it and I saw it there
Thank you for your reply and some clarification of the financing. I understand there was a “quiet period” the SEC required to submit to and hope we will now get back on track including your communications with shareholders.
I am sure you have your hands full and are very busy but I hope you can see this from a shareholders perspective especially many of us who have been with you a long time. We have all bought our stock on the open market at retail prices and have watched the share mostly erode over time but the success with Ebola gave us renewed hope we may start seeing some of the upward pricing we have all hoped for.
I am not sure where we are going to fit in with HCV since the new highly effective treatments have been getting approved and coming to the marketplace. These drugs are safe and effective, can be used in liver compromised patients with efficacy over 95% and greatly reduced treatment duration. While I am sure as time goes forward the high prices will have pressure to be drastically reduced with some exclusive contracts already happening so where is our niche going to be in all of this? What happened with India and the sale of the HP, I haven’t seen any revenue listed from those sales? What is happening on the DARPA front are we still on track. I have heard through other posters that Battelle is actually reviewing a different company and their filter, is this true?
We need revenue even with all the great things we have seen or been made aware of as this company goes forward we need real revenues and not continued dilution. I am also going to be direct, I hope you don’t mind. With my experience and knowledge I oppose a reverse split and have not had one good experience with companies I have owned who did this. Not one of them have ever been and all I ended up with was less share count, higher cost basis and lower share price because they all immediately dropped and never recovered.
I will close for now, take care Mr Joyce and remember ‘Remember when your Shareholders are Happy the whole Company is Happy’ that includes You.
Sincerely,
Saleem and Eleanora Nasser
- See more at: http://www.thechairmansblog.com/aethlon-medical/james-joyce/publication-describing-first-treatment-ebola-aethlon-hemopurifier/#AEMD
Patience is not simply the ability to wait - it's how we behave while we're waiting.
Better a diamond with a flaw than a pebble without one.
SEC Filings Get SEC Filings for:
Recent Filings
Date Form Title
Jan 21, 2015 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Summary - Full Filing at EDGAR Online(52kb)
Some number crunching from an establish company/competition.
On 5 May 2014, Genan celebrated the Grand Opening of its new, state-of-the-art tire recycling facility in Houston, Texas. The new factory is the largest of its kind in the world and has brought modernized, climate friendly recycling technology to the United States.
The Houston facility will employ approximately 60 workers and was constructed over the last two years with an investment of $140 million. The new plant has the capacity to recycle 100,000 tonnes of used tires a year, about a third of all the used tires in Texas.
Top 250 Canadian ICT Companies 2014
Prev 1-50 51-100 101-150 151-200 201-250 Next
Rank
2013 Rank
2012 Company Name Web Address City Province
51 46 Scalar Decisions www.scalar.ca Toronto ON
52 63 TekSavvy Solutions Inc www.teksavvy.com Chatham ON
53 66 Axia NetMedia www.axia.com Calgary AB
54 49 R3D Consulting www.r3d.com Montreal Quebec
55 60 Vision Critical www.visioncritical.com Vancouver BC
56 55 WiLAN www.wilan.com Ottawa ON
57 53 Vecima Networks www.vecima.com Victoria BC
58 73 Klick www.klick.com Toronto ON
59 59 Logibec www.logibec.com Montreal QC
60 64 Absolute Software www.absolute.com Vancouver BC
61 57 Adastra www.adastracorp.com Markham ON
62 65 iQmetrix www.iqmetrix.com Vancouver BC
63 76 PointClickCare www.pointclickcare.com Mississauga Ontario
64 52 VendTek Systems www.vendteksys.com Port Coquitlam BC
65 62 Systematix www.systematix.com Mississauga Ontario
66 67 Esri Canada www.esri.ca Toronto ON
67 75 VERITAAQ www.veritaaq.ca Ottawa Ontario
68 69 ESI Information Technologies www.esitechnologies.com Montreal QC
69 83 Solium www.solium.com Calgary AB
70 74 Computer Modelling Group www.cmgl.ca Calgary AB
71 71 Illumiti www.illumiti.com Richmond Hill Ontario
72 81 IMRIS www.imris.com Winnipeg MB
73 80 Mediagrif Interactive Technologies www.mediagrif.com Longueuil QC
74 89 Microserve www.microserve.ca Burnaby BC
75 70 AgJunction (formerly Hemisphere GPS) www.hemispheregps.com Calgary AB
76 79 Ideaca (now Hitachi Solutions Canada) www.ideaca.com Toronto ON
77 86 Zedi (technology segment) www.zedisolutions.com Calgary AB
78 78 Firan Technology Group www.ftgcorp.com Toronto ON
79 87 Distech Controls www.distech-controls.com Brossard QC
80 122 Fireswirl Technologies www.fireswirl.com Vancouver BC
81 84 TeraGo Networks www.terago.ca Thornhill ON
82 48 Maplesoft Group www.maplesoftgroup.com Ottawa ON
83 Halogen Software www.halogensoftware.com Ottawa ON
84 Tundra Technical Solutions www.tundratechnical.ca Toronto ON
85 105 ParetoLogic www.paretologic.com Victoria BC
86 107 TeliPhone www.teliphone.com Vancouver BC
87 92 WBM Office Systems www.wbm.ca Saskatoon SK
88 95 iWeb.com www.iweb.com Montreal QC 89 85 CriticalControl Solutions